The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials

ConclusionsThe comparison of real-life patients' characteristics with regulatory trials, displayed several apparent discrepancies. The demographic and clinical aspects were similar in all groups, whereas other features (eosinophil count, pulmonary function FEV1%) differed. These data, for the first time, could represent a basis for a more accurate prescription of the drug.
Source: World Allergy Organization Journal - Category: Allergy & Immunology Source Type: research